The Centers for Medicare & Medicaid Services (CMS) has announced a voluntary recalculation of 2027 Medicare Advantage (MA) Quality Bonus Payment (QBP) ratings for selected contracts. The decision follows a recent court ruling involving Clover Health that challenged the agency’s methodology for calculating star ratings.
The move could significantly affect bonus payments, plan bids, and competitive positioning for Medicare Advantage insurers. At the same time, CMS has assured insurers that recalculated ratings will only be adopted if they improve a contract’s score. Lower ratings will not reduce payments. This approach offers financial protection while addressing concerns raised by the court case.
CMS Announces Voluntary Recalculation of MA Bonus Ratings
CMS informed Medicare Advantage Organizations (MAOs) on June 17 that it would voluntarily recalculate 2027 Quality Bonus Payment ratings for certain contracts. Importantly, the agency stated that any recalculation producing a lower rating would not be implemented. Instead, insurers would retain their original bonus rating. This policy limits downside risk for plans while allowing them to benefit from favorable adjustments.
The agency’s decision arrives at a critical time. Medicare Advantage plans are finalizing bids and benefit designs for 2027. Therefore, updated ratings could influence reimbursement levels and market strategies.
Why Are Quality Bonus Payments Important?
Quality Bonus Payments reward Medicare Advantage plans that achieve strong star ratings. Plans earning four stars or more receive additional payments from CMS. These bonuses often translate into enhanced benefits, lower premiums, and expanded provider networks.
Moreover, star ratings influence how beneficiaries compare plans. A higher rating can improve enrollment and strengthen an insurer’s market position. Consequently, even a small rating increase can have substantial financial implications.
Why CMS Is Revisiting Star Ratings
The voluntary recalculation stems from a legal challenge brought by Clover Health. The company argued that CMS used inappropriate measures in calculating its ratings. A federal court sided with Clover and ordered CMS to recalculate the insurer’s 2026 Star Rating.
As a result, CMS increased Clover’s PPO contract rating from 3.5 stars to 4.5 stars for payment year 2027. The agency then extended the recalculation process to other eligible Medicare Advantage contracts.
This development marks an unusual shift in CMS policy. Although the agency retains the right to appeal the court decision, it has already begun implementing recalculated ratings operationally.
Court Ruling Creates Industry-Wide Effects
The ruling does not affect only one insurer. Instead, it raises broader questions about how CMS evaluates plan quality.
Industry observers believe that several plans could benefit from revised calculations. Some insurers may cross the important four-star threshold and become eligible for bonus payments. Others could receive higher rebates or adjust their bids based on improved ratings.
Impact on Medicare Advantage Insurers
The recalculation could reshape the competitive landscape for Medicare Advantage in 2027.
Insurers with upgraded ratings may receive larger bonus payments. In addition, they could use the extra funding to enhance benefits or reduce premiums. These advantages often attract more members and improve retention.
However, CMS has made it clear that plans will not face penalties if recalculations lower their scores. This “hold harmless” approach provides certainty while the agency resolves legal and policy questions.
Potential Effects on 2027 Bids
Some insurers may have an opportunity to revise their 2027 bids after receiving updated ratings. If that happens, companies could redesign benefits or adjust pricing strategies before the coverage year begins.
Therefore, insurers are closely monitoring CMS guidance and reviewing how recalculated ratings might affect future revenue streams.
What This Means for 2027 Medicare Advantage Payments
CMS finalized its 2027 Medicare Advantage and Part D payment policies earlier this year. The agency projects an average payment increase of 2.48%, representing more than $13 billion in additional payments to Medicare Advantage plans. Quality Bonus Payments remain a key component of that calculation.
Furthermore, CMS has introduced several changes to the Star Ratings program for 2027. The agency removed multiple administrative measures, retained the traditional reward factor, and postponed implementation of the Health Equity Index reward. These adjustments aim to simplify the program and focus more on clinical outcomes and patient experience.
A More Focused Star Ratings System
The updated framework places greater emphasis on meaningful quality measures. CMS believes this approach will reduce administrative burden while improving accountability.
As healthcare costs continue to rise, insurers will increasingly rely on strong quality scores to maintain profitability and attract members. Consequently, the recalculation process may have long-term implications beyond 2027.
The Future of CMS Star Ratings
The voluntary recalculation signals that CMS is willing to revisit its methodologies when courts or stakeholders identify concerns. It also highlights the growing importance of transparency and fairness in Medicare Advantage payment systems.
Looking ahead, insurers can expect continued changes to Star Ratings, risk adjustment, and bonus payment formulas. Therefore, health plans must remain flexible and invest in quality improvement strategies that align with CMS priorities.
Ultimately, the recalculation of 2027 MA bonus ratings may become a defining moment for Medicare Advantage. It not only affects payments today but also shapes how quality is measured in the future.
